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Abstract
Background: Low adherence to multidrug therapy against leprosy (MDT) is still an important obstacle of disease control,
and may lead to remaining sources of infection, incomplete cure, irreversible complications, and multidrug resistance.
Methodology/Principal Finding: We performed a population-based study in 78 municipalities in Tocantins State, central
Brazil, and applied structured questionnaires on leprosy-affected individuals. We used two outcomes for assessment of risk
factors: defaulting (not presenting to health care center for supervised treatment for .12 months); and interruption of MDT.
In total, 28/936 (3.0%) patients defaulted, and 147/806 (18.2%) interrupted MDT. Defaulting was significantly associated
with: low number of rooms per household (OR=3.43; 0.98–9.69; p=0.03); moving to another residence after diagnosis
(OR=2.90; 0.95–5.28; p=0.04); and low family income (OR=2.42; 1.02–5.63: p=0.04). Interruption of treatment was
associated with: low number of rooms per household (OR=1.95; 0.98–3.70; p=0.04); difficulty in swallowing MDT drugs
(OR=1.66; 1.03–2.63; p=0.02); temporal non-availability of MDT at the health center (OR=1.67; 1.11–2.46; p=0.01); and
moving to another residence (OR=1.58; 95% confidence interval: 1.03–2.40; p=0.03). Logistic regression identified
temporal non-availability of MDT as an independent risk factor for treatment interruption (adjusted OR=1.56; 1.05–2.33;
p=0.03), and residence size as a protective factor (adjusted OR=0.89 per additional number of rooms; 0.80–0.99; p=0.03).
Residence size was also independently associated with defaulting (adjusted OR=0.67; 0.52–0.88; p=0.003).
Conclusions: Defaulting and interruption of MDT are associated with some poverty-related variables such as family income,
household size, and migration. Intermittent problems of drug supply need to be resolved, mainly on the municipality level.
MDT producers should consider oral drug formulations that may be more easily accepted by patients. Thus, an integrated
approach is needed for further improving control, focusing on vulnerable population groups and the local health system.
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Introduction
Leprosy control is based on early diagnosis, treatment, and cure,
aiming at the elimination of sources of infection and of sequels in
affected individuals. Similar to other countries, in Brazil leprosy
control measures are integrated into general public health care,
thus facilitating access to affected individuals and reduction of
disease-related stigma [1].
Interruption and defaulting of multidrug therapy against
leprosy (MDT) are still important obstacles of disease control in
many endemic countries, with consequences for both patients
and the control programs: low adherence is responsible for
potentially remaining sources of infection, incomplete cure, and
irreversible complications, and in addition may lead to
multidrug resistance [2]. In Brazil, the number of patients
defaulting treatment was reduced from 3,148 individuals in
2002 to 529 in 2009 (with approximately 49,000 and 37,500
new cases, respectively) [3].
The causes leading to low adherence and non-compliance to
MDT are diverse and may include socio-economical, cultural,
psychosocial, behavioral, drug-related and disease-related
factors, as well as health service-related aspects [2,4–9]. For
www.plosntds.org 1 May 2011 | Volume 5 | Issue 5 | e1031example, a recent study from India identified stigma as the
most common reason given by defaulters, but failed to detail
data and to compare these factors with non-defaulters [4]. In
Paraı ´ba State in the northeast of Brazil, defaulting of MDT
was associated with regular alcohol use, but not with clinical
characteristics [5]. However, that study involved only 13
patients who defaulted, as compared to 28 patients finishing
treatment regularly. Here we present - as part of a major
epidemiological investigation in 78 municipalities in Brazil -
population-based data to further investigate factors associated
with interruption and defaulting of MDT in a hyperendemic
area.
Methods
Study area and population
Tocantins State is located in the central savannah region of
Brazil (Figure 1). The state has been created in 1988 and has a
total population of 1,3 million (2009), distributed throughout 139
municipalities; 83% of the municipalities have less than 10,000
inhabitants. Tocantins is hyperendemic for leprosy: in 2009, a
total of 1,345 new cases were notified, and the detection rate was
88.54/100.000 inhabitants.
The present study is part of a major epidemiological
investigation performed in 79 municipalities of northern Tocan-
tins. These municipalities are at highest risk for leprosy
transmission, according to a recent cluster analysis performed by
the Brazilian Ministry of Health (Figure 1) [10,11]. The target
population included all individuals newly diagnosed with leprosy
from 2006–2008, living and notified as leprosy cases in these
municipalities. We excluded the municipality of Araguaı ´na from
the present analysis, the biggest city in the region with about 120
thousand inhabitants. Araguaı ´na has a leprosy reference clinic and
shows different characteristics, as compared to the other smaller
Figure 1. Study area (dark gray area) in Tocantins State, Brazil. The light gray area indicates the cluster of high transmission risk situated in
the states Maranha ˜o, Para ´, Tocantins and Piauı ´.
doi:10.1371/journal.pntd.0001031.g001
Author Summary
Leprosy is still a public health problem in Brazil, and low
adherence to multidrug therapy against leprosy (MDT) is
an important obstacle of disease control. This may lead to
remaining sources of infection, incomplete cure, compli-
cations, and multidrug resistance. We performed a study in
78 municipalities in central Brazil, and interviewed leprosy-
affected individuals. In total, 3% of patients defaulted, and
18.2% interrupted MDT. Risk factors for interruption of
treatment include: reduced number of rooms per house-
hold (OR=1.95; p=0.04); difficulty in swallowing MDT
drugs (OR=1.66; p=0.02); temporal non-availability of
MDT drugs at health center (OR=1.67; p=0.01); and
moving residence after diagnosis (OR=1.58; p=0.03).
Defaulting MDT was significantly associated with: reduced
number of rooms per household (OR=3.43; p=0.03);
moving to another residence (OR=2.90; p=0.04); and low
family income (OR=2.42; p=0.04). Our study shows that
defaulting and interruption of MDT against leprosy are
associated with some poverty-related variables such as
family income, household size, and migration. Intermittent
problems of drug supply need to be resolved, mainly on
the municipality level. MDT producers should consider
drug formulations that are more easily accepted by
patients. An integrated approach is needed for further
improving control, focusing on most vulnerable popula-
tion groups and the local health system.
Interruption of Treatment against Leprosy
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will be published elsewhere.
We also excluded patients who moved to municipalities outside
the endemic cluster, suffered from mental disability or who have
shown other characteristics that impeded an interview, such as
individuals under the influence of alcohol. Relapsed leprosy cases
were also excluded. Individuals who had died after diagnosis were
not included in data analysis.
Study design and data collection
The 78 Municipal Health Secretariats were informed by the
Tocantins’ State Health Secretariat about the study and the
timeframe when the team would perform field visits for data
collection. Previous to field visits, the target population was
identified in the database of the National Information System
for Notifiable Diseases (Sistema de Informac ¸a ˜o de Agravos de
Notificac ¸a ˜o – SINAN). In the municipalities, the patients’ charts
and the local notification records were first reviewed regarding
clinical variables (clinical form, operational classification,
disability grade at diagnosis, mode of case detection, date of
diagnosis, date of release from treatment and date of last
appearance at health center for treatment). If in the local
records patients were identified that had not been notified, we
included them in the target population. Then, affected
individuals were invited by community health agents to be
interviewed at the local health care center. If individuals did
not present at the health care center, we performed home visits
accompanied by local community health agents. Data were
obtained at this occasion according to a previously defined
framework, using pre-tested structured questionnaires. The
framework comprised of four blocks of independent variables
possibly associated with the outcomes: 1. Socio-demographic
block (gender, age, marital status, education, residence area,
number of rooms, number of persons per household,
household income, migration); 2. Disease-related block (clin-
ical form of disease, operational classification, disability grade,
leprosy reaction, adverse events to MDT, difficulty swallowing
MDT drug); 3. Health service-related block (mode of case
detection, non-availability of MDT drugs, distance to health
care center, perceived difficult access to health care center); 4.
Knowledge, attitudes and practices block (alcohol consump-
tion, information of peer persons regarding disease, knowledge
on leprosy and cure). Data were collected from September to
December 2009.
To reduce inter-observer bias, all questionnaires where applied
by two previously trained field investigators (OAC, ARO) who
were supervised during the entire study. Data from patients’ charts
were collected by another two investigators (KH, FW). Extensive
pre-tests were performed under supervision.
Data entry and analysis
Data were entered twice, using Epi Info software version 3.5.1
(Centers for Disease Control and Prevention, Atlanta, USA) and
cross-checked for entry-related errors. Answers to open-ended
questions were grouped according to similarities and categorized
for bivariate analysis. Open-ended questions included information
on clinical characteristics for definition of leprosy reaction and
adverse events; and questions on knowledge, attitudes and
practices. Data analysis was done using STATA version 9 (Stata
Corporation, College Station, USA).
As the number of individuals defaulting MDT was relatively
low, two separate bivariate analyses were performed, with two
different outcomes based on the non-attendance of patients at
treatment centers:
1. Defaulting from treatment:
1. For this outcome, we used the definition of the Brazilian
Ministry of Health [12]: defaulters were defined as individuals
that did not complete MDT and who did not present to the
health care center for the monthly supervised treatment for at
least 12 months. We reviewed the most recently available
SINAN database of 2009 regarding this information and in
addition collected information on defaulting from the local
patients’ charts.
2. Interruption of treatment:
2. Interruption of MDT was defined as duration of treatment $7
months in the case of the paucibacillary form of disease (PB) or
$13 months in the case of the multibacillary form (MB).
Standard MDTs as set by the World Health Organization (and
adopted by the Brazilian Ministry of Health) are 6 four-week
blister packs for PB, and 12 four-week blister packs for MB
patients. Data analysis of interruption included only individuals
that had potential time to complete the treatment (all PB cases;
MB cases that had begun treatment $13 months previous to
data collection).
Variables were first analyzed and presented in a bivariate
manner. Odds ratios and their respective 95% confidence intervals
are given. We applied Fisher’s exact test to estimate significance of
the difference of relative frequencies. Continuous and discrete
variables were not normally distributed and thus compared
applying the Wilcoxon rank sum test for unmatched data.
Unconditional logistic regression analysis using backward
elimination was then performed to calculate adjusted odds
ratios for the independent association between 1) interruption
of; and 2) defaulting MDT, and the respective explanatory
variables. Results of both analyses are presented separately. In
addition to sex, age and leprosy form (PB/MB) which we used
as adjusting variables throughout multivariate analysis, vari-
ables with a p value,0.25 in the Fisher’s exact test were
entered into the initial regression models, and then backward
elimination was run. To remain in the model, a significance of
p,0.05 was required. Variables were checked for collinearity.
Confounding and interaction between variables were also
investigated by stratification and by constructing 262 tables.
All variables that remained in the final models are presented,
and odds ratios were adjusted for all other variables in the
respective model.
Ethics
The study was approved by the Ethical Review Board of the
Federal University of Ceara ´ (Fortaleza, Brazil) and by the Ethical
Review Board of Lutheran University of Palmas (Tocantins,
Brazil). Permission to perform the study was also obtained by the
Tocantins State Health Secretariat, the State Leprosy Control
Program and the municipalities involved.
Informed written consent was obtained from all study
participants after explaining the objectives of the study. In the
case of minors, consent was obtained from a caretaker.
Interviews were always performed separately to guarantee strict
privacy, and the diagnosis of leprosy was not given to family
members or other community members, in case the patient had
not revealed the diagnosis. If any leprosy-associated pathology
was observed during the interview or during clinical examina-
tion (data of clinical examination to be published elsewhere),
participants were referenced to the responsible health care
service.
Interruption of Treatment against Leprosy
www.plosntds.org 3 May 2011 | Volume 5 | Issue 5 | e1031Results
Study population and basic characteristics
Of the target population of 1635 individuals from 78
municipalities, 936 (57.2%) from 74 municipalities were included
in data analysis; one municipality did not diagnose a single case of
leprosy in the study period, and another three municipalities had
few cases, but no participants were included (non-consent or not
encountered). Twelve patients refused to participate in the study.
We excluded another 13 (five under of influence of alcohol that
impeded an interview; four convicted; three severely sick who were
hospitalized; and one due to advanced age). In addition, 674 were
not encountered even after home visits, were not known at the
local health centers, or had moved to another city outside the
cluster. For the analysis of interruption of MDT 130 individuals
were excluded (92 did not have information about date of the
beginning of treatment or last date of supervised monthly dose in
the health care center, and 38 were classified as MB leprosy with
treatment started ,13 months before data collection). Thus, data
analysis regarding defaulting included 936, and regarding
interruption 806 individuals. Information from patients’ charts
was available in 894 of cases.
Of the total of 936 individuals, 491 (52.5%) were males; the age
ranged from 5 to 98 years (mean=42.1 years; standard deviation:
18.8 years). Two-hundred and twenty-five (24.0%) were illiterate.
Median monthly family income was R$ 465 (about 270 USD at
the time of the study; interquartile range: R$ 300–R$ 900). In
total, 497 (55.6%) were classified as PB leprosy, and 395 (44.1%) as
MB.
We identified 28 (3.0%) patients who defaulted MDT; 16
defaulters were included by reviewing the SINAN data informa-
tion system, and an additional 12 locally in the patients’ charts.
Only 5 individuals were in the both databases. In total, 147/806
(18.2%) interrupted MDT.
Factors associated with interruption of MDT
Factors associated with interruption of MDT are detailed in
Table 1. Moving to another residence after diagnosis and living in
a small residence were significantly associated with interruption. In
addition, disease- and health service-related variables (difficulty in
swallowing MDT drug; temporal non-availability of MDT drugs)
were significantly associated with an increased chance of
interruption of treatment (Table 1). Interestingly, disease-related
factors such as the clinical form, presence of leprosy reactions or
occurrence of adverse events to MDT did not play a significant
role.
Figure 2 depicts the frequency of interruption of MDT,
stratified by age groups and gender. In general, the 16–30 year-
olds showed the highest chance of interruption, as compared to all
other age groups together (OR=1.84; 95% confidence interval:
1.20–2.77; p=0.04). This effect could be mainly attributed to the
16–30 year-old males, who showed the highest frequency of
interruption (34.4%), roughly a two-fold difference to females of
the same age group (17.6%; p=0.01; Figure 2).
Logistic regression analysis identified temporal non-availability
of MDT drugs at the health care center as an independent risk
factor for treatment interruption (Table 2). An increased number
of rooms per household (as an indicator for wealth) was identified
as an independent protective factor.
Factors associated with defaulting MDT
Bivariate analysis of factors associated with defaulting MDT is
depicted in Table 1. Several socio-economic variables (number of
rooms per household; moving to another residence after diagnosis;
family income) were significantly associated with defaulting
(Table 1). Similar to interruption of MDT, disease-related factors
did not play a significant role. Health service variables did also not
show any significant association.
In logistic regression analysis, we identified the number of
rooms per residence as a factor independently associated with
defaulting, with a protective odds ratio of 0.67 for each additional
room in the household (Table 2), but no other factors.
Discussion
Low adherence to drugs is in general a major obstacle in the
control of infectious diseases that require prolonged treatment,
such as leprosy and tuberculosis. Our comprehensive population-
based study shows that poverty, behavior, drug-related and
service-related factors were associated with adherence to MDT,
hampering leprosy control in a hyperendemic area in Brazil, and
suggest evidence-based actions for improving control measures.
It is widely believed that understanding and behavior of patients
in relation to drug compliance are largely influenced by their
socio-economic condition and level of knowledge; socio-economic
factors were previously suggested to influence adherence to MDT
[5,7,13]. Even though family income as a direct indicator of
poverty was not significantly associated with low adherence (but
with defaulting), number of rooms was identified as an
independent risk factor in both bivariate and multivariable
analyses. Poverty and its consequences, similar to other neglected
tropical diseases, has been shown to be associated with leprosy in
general [14], and our results reflect this complex interaction of
causation leading to higher risk of disease in underprivileged
populations.
In addition, population movements are usually associated with
socio-economic conditions in Brazil. In our study, people who had
moved to another residence were more vulnerable for low
adherence. These people may lose their bonds with community
health workers and other health professionals of the primary
health care centers, besides other factors that change in life when
moving to another place. Similar findings have been made in India
and southeast Brazil, where treatment interruption due to
migration has been reported [15,16]. In the case of tuberculosis,
moving to another district with subsequent change of health unit
was also shown to increase the risk of defaulting treatment in
Uganda [17]. On the other hand, changing residence due to
leprosy was clearly not a factor that played a role in our study (data
not shown).
Interestingly, the frequency of defaulting MDT was relatively
low, as compared to other settings [2,4,13,18,19], with a rate of
only 3%. In Tocantins, the defaulting rate was 47% in 2005, but
was reduced drastically in subsequent years [20]. This may reflect
the success of efforts made in the last years by Tocantins’s health
services. In fact, the Brazilian national and state leprosy control
programs have put a major effort in improving the decentralized
primary health care services, with 90% population coverage of the
Family Health Program in Tocantins. As another consequence,
variables related to health services seemed to play a minor role for
defaulting in our study, despite the identification of temporary
shortage of drugs as a significant risk factor for interruption of
MDT. We have shown previously that the patients of this area
answered most commonly to an open-ended question about the
reason for interrupting MDT with temporary shortage of drugs at
the health care center, but median time of interruption was only
15 days which indicates that this operational issue was usually
resolved quickly [21]. In fact, these logistical problems occurred
mainly on the municipality level, as MDT provided by the State
Interruption of Treatment against Leprosy
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Variables Interruption of MDT (n=806)* Defaulting MDT (n=936)*
Examined n Positive n (%) OR (95% CI) P value Examined n Positive n (%) OR (95% CI) P value
Socio-demographic
Gender
Male 429 88 (20.1) 1.39 (0.95–2.03) 0.08 491 14 (2.9) 0.90 (0.39–2.07) 0.85
Female 377 59 (15.7) Reference 445 14 (3.2) Reference
Age group (years)
0–15 67 9 (13.4) 0.70 (0.28–1.60) 0.46 77 3 (3.9) 1.20 (0.19–4.99) 0.60
16–30 181 47 (26.0) 1.59 (0.95–2.67) 0.07 207 7 (3.4) 1.00 (0.30–3.22) 1.00
31–45 205 37 (18.1) Reference 237 8 (3.4) Reference
46–60 200 32 (16.0) 0.86 (0.50–1.50) 0.60 234 8 (3.4) 1.01 (0.33–3.16) 1.00
$61 153 22 (14.4) 0.76 (0.41–1.40) 0.39 181 2 (1.1) 0.32 (0.03–1.63) 0.20
Marital status
Single 222 34 (15.3) 0.73 (0.46–1.14) 0.17 256 12 (4.7) 2.20 (0.89–5.43) 0.07
Married 479 95 (19.8) Reference 549 12 (2.2) Reference
Divorced 52 10 (19.2) 0.96 (0.42–2.04) 1.00 63 2 (3.2) 1.47 (0.16–6.82) 0.65
Widowed 52 8 (15.4) 0.73 (0.29–1.65) 0.58 67 2 (3.0) 1.38 (0.15–6.39) 0.66
Education
Never attended school 191 35 (18.3) 1.00 (0.63–1.55) 1.00 225 6 (2.7) 0.85 (0.28–2.21) 0.83
Attended school at any time 612 112 (18.3) Reference 707 22 (3.1) Reference
Residence area
Rural 219 45 (20.6) 1.24 (0.82–1.86) 0.30 252 9 (3.6) 1.30 (0.51–3.05) 0.52
Urban 586 101 (17.2) Reference 683 19 (2.8) Reference
Number of rooms per residence
1–2 55 16 (29.1) 1.95 (0.98–3.70) 0.04 59 5 (8.5) 3.43 (0.98–9.69) 0.03
$3 749 130 (17.4) Reference 874 23 (2.6) Reference
Number of persons/household
1–2 25 148 (16.9) 0.90 (0.54–1.47) 0.72 176 9 (5.1) 2.10 (0.82–4.96) 0.08
$3 657 121 (18.4) Reference 759 19 (2.5) Reference
Household income/month{
,R$ 465 199 34 (17.1) 0.92 (0.57–1.43) 0.75 232 12 (5.1) 2.42 (1.02–5.63) 0.04
$R$ 465 545 100 (18.4) Reference 681 15 (2.2) Reference
Moved to another residence after
diagnosis
Yes 179 43 (24.0) 1.58 (1.03–2.40) 0.03 210 11 (5.2) 2.9 (0.95–5.28) 0.04
No 624 104 (16.7) Reference 722 17 (2.4) Reference
Disease-related
Clinical form
Tuberculoid 148 25 (16.9) 0.91 (0.52–1.60) 0.8 156 9 (5.8) 1.03 (0.29–3.74) 0.6
Boderline 197 38 (19.3) 1.08 (0.65–1.76) 0.8 239 7 (2.9) 3.00 (0.92–10.3) 0.05
Lepromatous 83 14 (16.9) 1.12 (0.54–2.20) 0.9 91 1 (1.1) 0.53 (0.01–4.43) 1.0
Indeterminate 277 50 (18.1) Reference 290 6 (2.1) Reference
Operational classification
Multibacillary 331 67 (20.2) 1.27 (0.87–1.84) 0.23 496 17 (3.4) 0.74 (0.30–1.72) 0.56
Paucibacillary 473 79 (16.7) Reference 393 10 (2.5) Reference
Disability grade at diagnosis (DG)
DG II 26 7 (26.9) 1.48 (0.51–3.83) 0.44 – – – –
DG I 134 14 (10.5) 0.47 (0.24–0.87) 0.01 146 4 (10.5) 0.86 (0.20–2.74) 1.00
DG 0 422 84 (19.9) Reference 471 15 (19.9) Reference
Difficulty swallowing MDT drug
Interruption of Treatment against Leprosy
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Examined n Positive n (%) OR (95% CI) P value Examined n Positive n (%) OR (95% CI) P value
Yes 130 33 (25.4) 1.66 (1.03–2.63) 0.02 153 3 (2.0) 0.60 (0.11–2.01) 0.60
No 671 114 (17.0) Reference 778 25 (3.2) Reference
Type I or II leprosy reaction during
treatment (as reported by patient)
Yes 61 15 (24.6) 1.51 (0.76–2.86) 0.22 75 3 (4.0) 1.39 (026–4.73) 0.49
No 745 132 (17.7) Reference 861 25 (2.9) Reference
Adverse events to MDT (as reported
by patient)
Yes 389 73 (18.8) 1.07 (0.74–1.56) 461 13 (2.8) 0.89 (0.39–2.03) 0.85
No 417 74 (17.8) Reference 0.72 475 15 (2.9) Reference
Health service-related
Mode of case detection at primary
health care center
Spontaneous demand 555 101 (18.2) Reference 603 20 (3.3) Reference
Contact examination 35 5 (14.3) 0.75 (0.22–2.02) 0.66 47 2 (4.3) 1.30 (0.14–5.62) 0.67
Case detection campaign 15 5 (33.3) 2.25 (0.59–7.38) 0.17 157 1 (0.6) 0.19 (0.00–1.19) 0.01
Referred from other center 145 27 (18.6) 1.03 (0.62–1.67) 0.90 18 1 (5.6) 1.71 (0.04–12.07) 0.47
Other 10 1 (10) 0.50 (0.01–3.68) 1.00 10 1 (10) 3.24 (0.70–25.38) 0.30
Temporal non-availability of MDT
drug at health care center
Yes 228 55 (24.1) 1.67 (1.11–2.46) 0.01 265 9 (1.5) 1.19 (0.47–2.82) 0.67
No 573 92 (16.1) Reference 666 19 (2.9) Reference
Distance to health care center
.30 minutes 154 29 (18.3) 1.04 (0.64–1.65) 0.91 186 5 (2.7) 0.90 (0.26–2.45) 1.00
#30 minutes 634 116 (18.8) Reference 731 22 (3.0) Reference
Perceived difficult access to health
care center
Yes 172 35 (20.4) 1.18 (0.75–1.84) 0.44 201 3 (1.5) 0.42 (0.81–1.41) 0.17
No 620 110 (17.7) Reference 721 25 (3.5) Reference
Knowledge and attitudes
Continued drinking alcohol during
treatment
Yes 52 14 (26.9) 1.72 (0.83–3.35) 0.10 64 3 (4.7) 0.61 (0.17–3.25) 0.44
No/Never drunk 742 131 (17.7) Reference 858 25 (2.9) Reference
Told household members about
leprosy diagnosis
Yes 778 146 (18.8) Reference 0.01 907 27 (3.0) Reference
No 25 0 (0) 0 (0–0.67) 26 1 (3.9) 1.30 (0.31–8.6) 0.55
Knew leprosy before diagnosis
Yes 697 121 (17.4) Reference 808 23 (2.9) Reference
No 105 26 (24.8) 1.57 (0.92–2.59) 0.08 124 5 (4.0) 1.43 (0.42–3.96) 0.40
Knew someone with leprosy before
diagnosis
Yes 518 86 (16.6) Reference 610 16 (2.6) Reference
No 282 61 (21.6) 1.39 (0.94–2.03) 0.09 319 12 (4.0) 1.45 (0.62–3.31) 0.41
Thinks that leprosy is curable
Yes 728 127 (29.0) Reference 847 25 (3.0) Reference
No 38 11 (17.5) 1.92 (0.84–4.14) 0.08 46 3 (6.5) 2.29 (0.43–7.97) 0.17
Does not know 37 8 (21.6) 1.31 (0.50–3.01) 0.51 – – – –
*Information not available in all cases.
{At the time of the survey 1US$ was equivalent to 1.72R$,a n dR $ 465,- the official minimum wage as set by the Federal Government.
doi:10.1371/journal.pntd.0001031.t001
Table 1. Cont.
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shortage in the study period (A.C.F., unpublished observation). In
other countries and settings, where leprosy control programs are
not yet well established, such as in northern Mozambique, Nigeria
and Sudan, health-service related factors play a more crucial role
[4,7,18,19,22].
Our data also indicate that in a setting with an established
leprosy control program, clinical variables are of minor impor-
tance for low adherence to MDT. In case of leprosy reactions, for
example, the primary health care services and the reference
centers seem to be prepared to cope with the situation. Similarly,
previous studies from northeast Brazil, the Philippines and Nepal
suggested that clinical data such as type of leprosy, occurrence of
reactions or disability grading at diagnosis would not play a
significant role in the given context [2,5,23]. Difficulty in
swallowing drugs was previously suggested as a factor associated
with low adherence to MDT [2]. Considering also the long course
of treatment, this shows the need for the search of new
formulations that may be better accepted by patients.
Studies from other parts of the world, mainly from the South
Asian and Southeast Asian sub-regions, identified other risk factors
for low adherence. For example, in the Philippines adverse events
were given by the patients as the most important reason (40%) for
defaulting [2]. People in Assam (India) who defaulted treatment
mentioned loss of occupational hours when going to the health
care center (33,1%), adverse events (26,0%) and social stigma
Figure 2. Relative frequency of interruption of MDT, stratified by gender and age group.
doi:10.1371/journal.pntd.0001031.g002
Table 2. Multivariate logistic regression analysis of factors associated with interruption of, and defaulting multidrug therapy
against leprosy, adjusted by sex, age and disease classification.
Variables Interruption of MDT Defaulting MDT
Adjusted OR
(95% CI) P value
Adjusted OR
(95% CI) P value
Temporal non-availability of
drugs at health care center
1.56 (1.05–2.33) 0.03 – –
Each additional room per residence 0.89 (0.80–0.99) 0.03 0.67 (0.52–0.88) 0.003
Male sex 1.35 (0.93–1.97) 0.12 0.79 (0.36–1.72) 0.55
Age group 16–30 years 0.99 (0.98–1.00) 0.13 1.05 (0.43–2.56) 0.91
Multibacillary disease 1.12 (0.76–1.66) 0.56 0.70 (0.31–1.56) 0.38
doi:10.1371/journal.pntd.0001031.t002
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these factors were identified in a qualitative study from Espı ´rito
Santo State in Brazil [16]. Since then, Brazilian control programs
have improved considerably, e.g. by performing health education
on adverse events and leprosy reactions, by training health care
professionals and by improved access of the users to the primary
health care system. The results of our study reflect these efforts and
highlight the differing situation in other countries.
Available evidence on the influence of demographic variables
on adherence to treatment is contradictory. Similar to the study
from the Philippines [2], demographic data such as gender, age
and civil status were not associated with low adherence in our
study population. In contrast, in endemic regions of Nepal and
India, more males than females completed treatment, and
illiteracy was also significantly associated with low treatment
compliance [9,13]. However, both studies had some methodolog-
ical problems, and analysis of data is limited. Interestingly, our
study showed highest interruption rates in young males, when data
were stratified by gender. This indicates that factors are
multifaceted and that in this case, young males, who are generally
known to show insufficient health care behavior, should be
considered a vulnerable group for low adherence. In fact, the
Brazilian Ministry of Health has taken into consideration the
special needs of the male population and recently launched an
integrative program focusing on male gender issues [24].
Similar to leprosy, tuberculosis needs prolonged treatment and
has also shown to reveal problems regarding adherence.
Improving adherence to treatment against leprosy can thus be
expected to have positive impact also on other diseases, such as
tuberculosis. In fact, the factors associated with low adherence to
tuberculosis are similar. For example, in Ethiopia, the occurrence
of adverse events to tuberculosis treatment was found to be a
significant risk factor for defaulting, whereas knowledge about
duration of treatment was protective and increased the odds of
terminating treatment [25]. A study from Nepal identified distance
to health care services and low knowledge on disease and its
treatment as risk factors for non-adherence to tuberculosis directly
observed short-course (DOTS) [26].
An ancillary finding was the detection of incomplete patients’
charts and registries in many cases. We detected in total 128
leprosy cases that were not included in the national SINAN
database for notifiable diseases, and a considerable number of
cases of abandonment from treatment, which had not been
registered as such in SINAN. In addition, only in 72.1% (645/894)
information on degree of disability at diagnosis was available in the
patients’ charts. The quality of patients’ records and datasets has
improved in the past years, but there is still a clear need for more
complete data sets and patient charts, as suggested recently in a
study performed in northeast Brazil [27].
Though being a population-based study performed in a
considerable number of municipalities in a leprosy hyperendemic
region, our study is subject to limitations. First, the number of
defaulters, as a result of the ongoing leprosy control measures, has
been reduced significantly in the past years, and we included only
28 patients who defaulted treatment. This hampered statistical
analysis to some degree. Second, non-participation bias, mainly of
those who abandoned treatment, may have played a role. Thus,
we performed an additional analysis using a less stringent criterion
for compliance: interruption of treatment, based on the duration
of treatment. However, this analysis did not take into account
adherence to drugs taken at home, but was based on appearance
at the health care centers for the monthly supervised dose, which
should be taken into account in the interpretation of results.
Finally, incomplete patients’ charts and subsequent missing data
hampered analysis regarding clinical variables in some cases. On
the other hand, integration of local primary health care
professionals and of the State and Municipal Leprosy Control
Programs reduced non-participation bias.
We conclude that in an area in Brazil where leprosy control
actions are well established, adherence to MDT is a result of a
complex interaction between different socio-cultural, service-
related, drug-related and economical factors. Intermittent prob-
lems of drug supply need to be resolved, mainly on the
municipality level. MDT producers should consider oral drug
formulations that may be more easily accepted by patients. An
integrated approach is needed to further improve adherence and
other aspects of leprosy control, such as early diagnosis, including
the stakeholders involved: patients and their families, health care
professionals, and policy makers [6,28,29]. Improved adherence to
MDT will further improve the leprosy control programs and in
addition minimize the risk of possibly upcoming drug resistance.
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